Indian COVID Vaccine Covaxin Expected To Be Nearly 60% Effective

Hyderabad: Bharat Biotech’s COVID-19 vaccine is expected to be more than 50 per cent effective, to nearly 60 per cent.

In comparison, Moderna and Pfizer vaccines are believed to be more than 90 per cent effective. However, top US immunologist Dr Anthony Fauci had earlier said 50-60 per cent effective vaccine is good enough to control the pandemic.

The vaccine will be rolled out around June 2021, according to the company.

The phase 3 trials started earlier this month. It is being tested on 26,000 participants across 25 hospitals in the country.

Recently, it was revealed that a participant in the phase 1 trial developed an adverse reaction in August.

This vaccine is an inactivated one and it introduces a part of the virus into the human body to provoke an immune response that the body will remember to use when an actual infection comes.